FDA Inspection 1195197 — Harbinger Medical Group
The FDA completed an inspection of Harbinger Medical Group on Dec 9, 2022 in Lafayette, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 9, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Lafayette, LA (United States)